期刊文献+

Hepatocellular Carcinoma in Benin City, Nigeria: A Twenty-Five (1987-2011) Year Retrospective Histopathological Study

Hepatocellular Carcinoma in Benin City, Nigeria: A Twenty-Five (1987-2011) Year Retrospective Histopathological Study
下载PDF
导出
摘要 Aim: To evaluate the demographic characteristics and histological variants of hepatocellular carcinoma (HCC) in Benin City. Methodology: The surgical daybooks of the Department of Anatomic Pathology, University of Benin Teaching Hospital were used for data collection. All the liver biopsies received in the period (1987-2011) under review diagnosed with HCC were analysed using SPSS version 16.0. Results: The male to female ratio was 2:1 and the peak age of incidence was in the 50 - 60 years age group. The mean ages were 44.24 ± 18.52 and 48.75 ± 12.92 and the age ranges were 1.5 to 82 years and 20 to 68 years for males and females respectively. The modal age was 60 years. Histological variants of hepatocellular carcinoma were the pseudoglandular/acinar pattern which accounted for 26 cases (44.07%), followed by the trabeculae pattern 17 cases (28.81%), the compact/solid variant 10 cases (16.95%) and the fibrolamellar pattern which was 6 cases (10.17%). Conclusion: Hepatocellular carcinoma has divergent demographic and histological characteristics which have clinical implications on the treatment outcomes;hence pathologists are encouraged to include the subtype in their reports for prognostication. Aim: To evaluate the demographic characteristics and histological variants of hepatocellular carcinoma (HCC) in Benin City. Methodology: The surgical daybooks of the Department of Anatomic Pathology, University of Benin Teaching Hospital were used for data collection. All the liver biopsies received in the period (1987-2011) under review diagnosed with HCC were analysed using SPSS version 16.0. Results: The male to female ratio was 2:1 and the peak age of incidence was in the 50 - 60 years age group. The mean ages were 44.24 ± 18.52 and 48.75 ± 12.92 and the age ranges were 1.5 to 82 years and 20 to 68 years for males and females respectively. The modal age was 60 years. Histological variants of hepatocellular carcinoma were the pseudoglandular/acinar pattern which accounted for 26 cases (44.07%), followed by the trabeculae pattern 17 cases (28.81%), the compact/solid variant 10 cases (16.95%) and the fibrolamellar pattern which was 6 cases (10.17%). Conclusion: Hepatocellular carcinoma has divergent demographic and histological characteristics which have clinical implications on the treatment outcomes;hence pathologists are encouraged to include the subtype in their reports for prognostication.
出处 《Health》 2019年第9期1177-1185,共9页 健康(英文)
关键词 HEPATOCELLULAR CARCINOMA BENIN City NIGERIA Hepatocellular Carcinoma Benin City Nigeria
  • 相关文献

参考文献1

二级参考文献15

  • 1Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CACancer J Clin, 2005, 55:10-30.
  • 2E1-Serag HB, Mason AC. Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med, 2000, 160:3227-3230.
  • 3Evans AA, Chen G, Ross EA, et al. Eight-year follow-up of the 90,000-person Haimen City cohort: I. Hepatocellular carcinoma mortality, risk factors, and gender differences. Cancer Epidemiol Biomarkers Prey, 2002, 11:369-376.
  • 4Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med, 1996, 334:693-699.
  • 5Llovet JM, Di Bisceglie AM, Bruix J, et al. Design and endpoints of clinical trims in hepatocellular carcinoma. J Natl Cancer Inst, 2008, 100:698-711.
  • 6Zavaglia C, De Carlis L, Alberti AB, et al. Predictors of long- term survival after liver transplantation for hepatocellular carcinoma. Am J Gastroenterol, 2005, 100:2708-2716.
  • 7Roayaie S, Schwartz JD, Sung MW, et al. Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis, Liver Transpl, 2004, 10:534-540.
  • 8Schlitt H J, Neipp M, Weimann A, et al. Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation. J Clin Oncol, 1999, 17:324-331.
  • 9Todo S, Furukawa H. Living donor liver transplantation for adult patients with hepatoeellular carcinoma: experience in Japan. Ann Surg, 2004, 240:451-459.
  • 10L~he F, Angele MK, Gerbes AL, et al. Tumour size is an important predictor for the outcome after liver transplantation for hepatocellular carcinoma. Eur J Surg Oncol,2005,31:994-999.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部